Skip to main content
Livermore
Livermore
ZHEN

Accelerate Diagnostics, Inc

AXDXDelisted Jul 21, 2025
Industry
Laboratory Analytical Instruments
SEC CIK
0000727207

Accelerate Diagnostics, Inc was delisted on Jul 21, 2025; its insiders filed their last Form 4 on Apr 7, 2025; 43 institutions reported holding it in 13F filings for Q1 2025, worth $3.10M in total; no superinvestor held it.

Q1 2025 vs. Q4 2024

How the institutions holding Accelerate Diagnostics, Inc changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of AXDX: Q4 2024 compared with Q1 2025
MeasureQ4 2024Of which not filed for Q1 2025Q1 2025Change
Holders47143−3
Shares4.72M1404.43M−286.3K (−6.1%)
Value$5.69M$231$3.10M−$2.58M (−45.4%)

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (4)

Institutions that held Accelerate Diagnostics, Inc at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to AXDX in Q1 2025
InstitutionSharesValue% of portfolio
Lido Advisors, LLC163,161$114.4K0.00%
Advisor Group Holdings, Inc.889$6220.00%
Tower Trust & Investment Co140$720.00%
SBI Securities Co., Ltd.3$20.00%

Sold out (7)

Institutions that held Accelerate Diagnostics, Inc at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of AXDX in Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Jane Street Group, LLC22,415$26.9K
Millennium Management LLC14,930$17.9K
Virtu Financial LLC11,214$13.0K
Citigroup Inc10,678$12.8K
Stratos Wealth Partners, LTD.10,628$12.8K
Royal Bank of Canada4,776$6.00K
Steward Partners Investment Advisory, LLC527$632

Not filed for Q1 2025 yet (1)

Institutions that held Accelerate Diagnostics, Inc at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AXDX in Q4 2024 that haven't filed for Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Northwest Bank & Trust Co140$231